Metabolic & Cardiometabolic
bariatric surgery decreases cardiovascular events
In plain terms: Does bariatric surgery reduce cardiovascular events?
Part of: 🩺 bariatric / metabolic surgery
Yes—observational cohorts and meta-analyses consistently show ~40-50% lower MACE/MI, though no dedicated CV-outcome RCT and residual confounding remain.
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
The evidence (9)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Sjostrom 2014 · JAMA | observational | supports | high | SOS: surgery reduced macrovascular (CV) complications alongside diabetes remission over long-term. |
| Zhou 2016 · Obes Surg | meta-analysis | supports | moderate | Landmark systematic review found bariatric surgery associated with reduced cardiovascular events versus non-surgical treatment in obese patients. |
| Salib 2026 · Am J Cardiol | meta-analysis | supports | high | MI HR 0.61, new heart failure HR 0.55, stroke HR 0.80, AF HR 0.70—broad CV benefit, consistent across procedures. |
| Yan 2019 · PLoS One | meta-analysis | supports | moderate | 4 RCTs + 6 cohorts: macrovascular complications RR 0.43, CV events HR 0.52, MI RR 0.40 over >5yr. |
| Chen 2025 · Int J Obes | meta-analysis | supports | moderate | Umbrella review: among weight-control interventions, surgery showed most consistent CV-outcome benefit. |
| Yang 2023 · Obes Surg | meta-analysis | supports | moderate | Matched/prospective cohorts (122k) diabetic obese: significantly reduced MACE after metabolic/bariatric surgery. |
| Qazi 2026 · Obes Surg | meta-analysis | mixed | moderate | In pre-existing CVD: MACE HR 0.55 significant, but MI (HR 0.53) and cerebrovascular events (HR 0.99) non-significant—benefit not uniform. |
| Tang 2022 · Surg Obes Relat Dis | meta-analysis | supports | high | 21 population cohorts (2.86M): MACE RR 0.53, MI RR 0.40, stroke RR 0.60, CV death RR 0.43. |
| Obeso-Fernandez 2024 · Surg Obes Relat Dis | meta-analysis | supports | high | 16 studies (179k) T2D: any CV event RR 0.56, MI RR 0.46, heart failure RR 0.29, CV mortality RR 0.31. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.